Free Trial

HC Wainwright Estimates Transcat's Q2 Earnings (NASDAQ:TRNS)

Transcat logo with Computer and Technology background

Key Points

  • HC Wainwright has raised its Q2 2026 earnings per share estimate for Transcat (NASDAQ:TRNS) from $0.43 to $0.48, maintaining a "Buy" rating with a target price of $116.00.
  • Transcat recently reported a Q2 profit of $0.59 EPS, exceeding analysts' expectations, and had a revenue of $76.42 million, surpassing consensus estimates.
  • Institutional investors hold 98.34% of Transcat's stock, indicating strong interest from large financial entities in the company.
  • Want stock alerts on Transcat? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Stock analysts at HC Wainwright increased their Q2 2026 earnings per share estimates for shares of Transcat in a report released on Monday, August 11th. HC Wainwright analyst S. Buck now anticipates that the scientific and technical instruments company will earn $0.48 per share for the quarter, up from their previous forecast of $0.43. HC Wainwright has a "Buy" rating and a $116.00 price objective on the stock. The consensus estimate for Transcat's current full-year earnings is $2.30 per share. HC Wainwright also issued estimates for Transcat's Q3 2026 earnings at $0.47 EPS and FY2027 earnings at $2.58 EPS.

Several other research firms also recently issued reports on TRNS. Wall Street Zen upgraded Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday, May 28th. Lake Street Capital assumed coverage on Transcat in a report on Thursday, July 10th. They set a "buy" rating and a $105.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $112.20.

View Our Latest Research Report on TRNS

Transcat Stock Up 0.3%

TRNS stock opened at $79.38 on Tuesday. The company has a current ratio of 2.92, a quick ratio of 2.36 and a debt-to-equity ratio of 0.11. The firm has a market cap of $739.82 million, a PE ratio of 55.51 and a beta of 0.71. Transcat has a 1 year low of $67.56 and a 1 year high of $133.72. The company has a fifty day simple moving average of $81.79 and a 200 day simple moving average of $80.46.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.19. The firm had revenue of $76.42 million for the quarter, compared to the consensus estimate of $72.28 million. Transcat had a return on equity of 6.66% and a net margin of 4.64%.

Hedge Funds Weigh In On Transcat

Large investors have recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new position in shares of Transcat during the first quarter valued at about $76,000. Parkside Financial Bank & Trust acquired a new position in Transcat in the 2nd quarter valued at approximately $79,000. PNC Financial Services Group Inc. lifted its position in shares of Transcat by 1,118.2% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company's stock worth $92,000 after acquiring an additional 984 shares during the period. State of Wyoming acquired a new stake in shares of Transcat during the 1st quarter worth approximately $95,000. Finally, Morgan Dempsey Capital Management LLC increased its position in shares of Transcat by 41.7% during the second quarter. Morgan Dempsey Capital Management LLC now owns 1,352 shares of the scientific and technical instruments company's stock valued at $116,000 after purchasing an additional 398 shares during the period. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Company Profile

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More

Earnings History and Estimates for Transcat (NASDAQ:TRNS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Transcat Right Now?

Before you consider Transcat, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.

While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines